SUSAN MATTHEWS: Open Payments
NPI 1881637304 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,028 in 105 payments from 17 companies in 2025. Trend: 2023 $2,502 · 2024 $1,993 · 2025 $2,028
Food & beverage: $2,028
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 57 | $1,042 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $191 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $136 |
| Ardelyx, Inc. | 5 | $93 |
| Janssen Biotech, Inc. | 5 | $91 |
| GENZYME CORPORATION | 4 | $89 |
| Madrigal Pharmaceuticals | 3 | $89 |
| PFIZER INC. | 3 | $66 |
| QOL Medical, LLC | 3 | $65 |
| Gilead Sciences, Inc. | 2 | $43 |
Products named: RINVOQ, VIBERZI, ENTYVIO, SKYRIZI, XIFAXAN, IBSRELA, TREMFYA, DUPIXENT.
Industry payments across TN — which companies pay providers there.
